Tilia Fiduciary Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-983
Closed -$75.7K 159
2023
Q2
$75.7K Sell
983
-120
-11% -$9.29K 0.07% 162
2023
Q1
$82.9K Hold
1,103
0.08% 158
2022
Q4
$86.9K Hold
1,103
0.08% 150
2022
Q3
$76K Hold
1,103
0.08% 156
2022
Q2
$86K Hold
1,103
0.08% 149
2022
Q1
$84K Hold
1,103
0.07% 169
2021
Q4
$94K Buy
+1,103
New +$86.1K 0.08% 162

Other funds holding CL

Tilia Fiduciary Partners's CL Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 983 shares — an estimated $75.7K sold.

Tilia Fiduciary Partners first reported a position in CL in Q4 2021 and held it in 7 quarters. The position peaked at $94K in Q4 2021. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 983 Colgate-Palmolive shares in Q3 2023, an estimated $75.7K.
  • Tilia Fiduciary Partners first reported a position in Colgate-Palmolive in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's Colgate-Palmolive position peaked at $94K in Q4 2021.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.